Literature DB >> 19966937

Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis.

Ming Yin, Zhibin Hu, Dongfeng Tan, Jaffer A Ajani, Qingyi Wei.   

Abstract

Gastric cancer is a disease of gene-environment interactions, as suggested by the varying geographic patterns of its incidence. Even in areas with high rates of Helicobacter pylori infection, only a small proportion of infected individuals develop gastric cancer. Genetic susceptibility to gastric cancer can be investigated by common genetic variants, such as single nucleotide polymorphisms (SNPs), in various genes that regulate multiple biological pathways. The susceptibility to gastric carcinogenesis has a substantial influence on the population attributable risk by modulating the effects of environmental risk factors. Despite recent progress in the field of the molecular epidemiology of cancer, a re-evaluation of gastric cancer susceptibility and potentially functional SNPs in candidate genes is necessary, given the inconsistency of previous reported studies. This review focuses on genetic variants that contribute to the etiology of gastric cancer, particularly those SNPs involved in inflammatory response, metabolism of chemical carcinogens, DNA repair, and tumor suppression. In the future, well-designed large multicenter population-based studies will be needed to validate current findings and provide the rationale for identifying at-risk subpopulations for primary prevention of gastric cancer.

Entities:  

Keywords:  Gastric cancer; Genetic polymorphism; Meta-analysis

Year:  2009        PMID: 19966937      PMCID: PMC2776284     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  105 in total

1.  Genetic polymorphisms of XRCC1 and risk of gastric cancer.

Authors:  Seong-Gene Lee; Byungsik Kim; Jaewon Choi; Changhoon Kim; Inchul Lee; Kyuyoung Song
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

2.  Cytokine inhibition of gastric acid secretion--a little goes a long way.

Authors:  M M Wolfe; D J Nompleggi
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

Review 3.  Mechanisms of nitrosamine bioactivation and carcinogenesis.

Authors:  C S Yang; T J Smith
Journal:  Adv Exp Med Biol       Date:  1996       Impact factor: 2.622

4.  Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.

Authors:  K R Kaderlik; G J Mulder; R J Turesky; N P Lang; C H Teitel; M P Chiarelli; F F Kadlubar
Journal:  Carcinogenesis       Date:  1994-08       Impact factor: 4.944

5.  Glutathione S-transferase M1 gene null genotype and gastric cancer risk in Taiwan.

Authors:  Kuang-Chi Lai; Wen-Chi Chen; Fuu-Jen Tsai; Shuan-Yow Li; Ming-Chih Chou; Long-Bin Jeng
Journal:  Hepatogastroenterology       Date:  2005 Nov-Dec

Review 6.  XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.

Authors:  Zhibin Hu; Hongxia Ma; Feng Chen; Qingyi Wei; Hongbing Shen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

7.  E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.

Authors:  K F Becker; M J Atkinson; U Reich; I Becker; H Nekarda; J R Siewert; H Höfler
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

8.  Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B -31 C/+ and IL-1RN *2/*2) and gastric cancer/duodenal ulcer in Korean population.

Authors:  Seong-Gene Lee; Byungsik Kim; Wonyong Choi; Inchul Lee; Jaewon Choi; Kyuyoung Song
Journal:  Cytokine       Date:  2003-02-21       Impact factor: 3.861

9.  Trp53-dependent DNA-repair is affected by the codon 72 polymorphism.

Authors:  M Siddique; K Sabapathy
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

10.  Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.

Authors:  S Kato; M Onda; N Matsukura; A Tokunaga; N Matsuda; K Yamashita; P G Shields
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

View more
  21 in total

1.  Sentinel lymph node and prognostic factors in gastric cancer.

Authors:  E Orsenigo; S Kusamura; C Staudacher
Journal:  Surg Endosc       Date:  2011-11       Impact factor: 4.584

2.  Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?

Authors:  Hilda Wong; Thomas Yau
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

3.  First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile.

Authors:  Ricardo Marcos-Pinto; Mário Dinis-Ribeiro; Fátima Carneiro; Xiaogang Wen; Carlos Lopes; Céu Figueiredo; José Carlos Machado; Rui M Ferreira; Celso A Reis; Paulo Canedo; Cecília Durães; José Ferreira; Isabel Pedroto; Jorge Areias
Journal:  Virchows Arch       Date:  2013-07-26       Impact factor: 4.064

Review 4.  Targeting receptor tyrosine kinases in gastric cancer.

Authors:  Asahiro Morishita; Jian Gong; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer.

Authors:  M S Al-Moundhri; I Al-Hadabi; K Al-Mawaly; S Kumar; F A R Al-Lawati; G Bhatnager; S Kuruvila; A Al-Hamdani; S M El-Sayed; B Al-Bahrani
Journal:  Med Oncol       Date:  2011-11-03       Impact factor: 3.064

6.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

7.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

8.  MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Authors:  Aoran Guan; Hui Wang; Xun Li; Hui Xie; Ruotian Wang; Yankun Zhu; Ruhong Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

9.  An updated meta-analysis of transforming growth factor-β1 gene: three polymorphisms with gastric cancer.

Authors:  Wei-wei Chang; Liu Zhang; Hong Su; Ying-shui Yao
Journal:  Tumour Biol       Date:  2013-11-20

10.  Comparative analysis of the interaction of HSPs in dendritic cells, macrophages, RGM-1 cells infected by Helicobacter pylori.

Authors:  Yongliang Yao; Jianhong Wu; Tao Gu; Yang Cheng; Guangxin Li
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.